With offices in France (Paris) and in the USA (Princeton, New Jersey), STENTYS became listed on the Paris EuroNext stock exchange (STNT.PA) in October 2010. STENTYS® received CE-Marking for its BMS and DES(P) stents in early 2010 and currently sells its products in more than 8 European countries.
The STENTYS Clinical Program includes both randomised trials and real-life registries, evaluating the STENTYS stent in STEMI with the APPOSITION program, and in bifurcations with the OPEN program. STENTYS has started a 3,000 patient post-market registry in 2012 to examine the real-world use of the STENTYS stent where stent sizing is a concern.
Market capitalization (24-Sept-2020)
Closing stock price (24-Sept-2020)
Stentys has 475 Twitter Followers. The number of followers has increased 0.7% month over month and increased 0.5% quarter over quarter
When was Stentys founded?
Stentys was founded in 2006.
How many employees does Stentys have?
Stentys has 7 employees.
Who are Stentys competitors?
Competitors of Stentys include ForTec Medical, Mobile Instrument Service & Repair and ATL Technology.
Where is Stentys headquarters?
Stentys headquarters is located at 17 Av. de la Métallurgie, Saint-Denis.
Where are Stentys offices?
Stentys has offices in Saint-Denis and Princeton.
How many offices does Stentys have?
Stentys has 2 offices.
Receive alerts for 300+ data fields across thousands of companies